Physician profile
Robert D Jongco
NPI 1477848919
$6,872.99
in general payments reported to CMS, 2019-2025
23 companies · $3,914 in 2025
The $3,914 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $219 · 2022: $532 · 2023: $298 · 2024: $1,590 · 2025: $3,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,557 · Travel and Lodging: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,557.37 |
| Travel and Lodging | $2,245.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,314.74 | 2024-2025 | Evoke |
| Nevro Corp. | $984.35 | 2019-2024 | Senza |
| Mml US, INC. | $976.03 | 2025 | Reactiv8 |
| Boston Scientific Corporation | $904.88 | 2019-2024 | |
| Abbott Laboratories | $409.20 | 2019-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $334.90 | 2025 | Senza |
| Medtronic, INC. | $165.87 | 2022-2024 | Intellis Adaptivestim |
| Stryker Corporation | $150.70 | 2024-2025 | Mild Device Kit, Optablate |
| Vertos Medical, INC. | $146.29 | 2024 | Mild Device Kit |
| Biotronik Nro, INC. | $128.68 | 2025 | Prospera |
| Spr Therapeutics, INC | $74.07 | 2025 | Sprint Pns System |
| Abbvie INC. | $64.01 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $54.91 | 2025 | Xeomin |
| Scilex Pharmaceuticals INC. | $27.12 | 2019 | |
| Averitas Pharma INC. | $19.20 | 2025 | Qutenza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $19.17 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.40 | 2025 | Dysport |
| Pacira Therapeutics, INC. | $14.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.86 | 2019 | |
| Biodelivery Sciences International, INC. | $13.73 | 2019 | |
| Merck Sharp & Dohme LLC | $13.15 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.10 | 2019 | |
| Kaleo, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jongco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.